ABBV
AbbVie IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$368.38B
P/E Ratio
102.21
EPS
$2.04
Beta
0.30
52W High
$239.13
52W Low
$174.56
50-Day MA
$210.70
200-Day MA
$218.58
Dividend Yield
3.24%
Profit Margin
5.79%
Forward P/E
14.14
PEG Ratio
0.56
About AbbVie Inc
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Fundamentals
| Revenue (TTM) | $62.82B |
| Gross Profit (TTM) | $45.25B |
| EBITDA | $29.92B |
| Operating Margin | 32.20% |
| Return on Equity | 62.30% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $35.50 |
| Book Value | $-3.77 |
| Price-to-Book | 50.46 |
| Price-to-Sales (TTM) | 5.70 |
| EV/Revenue | 6.67 |
| EV/EBITDA | 47.51 |
| Quarterly Earnings Growth (YoY) | -46.20% |
| Quarterly Revenue Growth (YoY) | 12.40% |
| Shares Outstanding | $1.77B |
| Float | $1.76B |
| % Insiders | 0.11% |
| % Institutions | 77.48% |
Historical Volatility
HV 10-Day
27.72%
HV 20-Day
25.81%
HV 30-Day
25.59%
HV 60-Day
25.76%
HV Rank
48.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($252.23 target)
8
Strong Buy16
Buy8
HoldMore HEALTHCARE Stocks
Data last updated: 5/14/2026